Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer
収録刊行物
-
- Clinical Lung Cancer
-
Clinical Lung Cancer 18 (1), 96-99, 2017-01
Elsevier BV
